4/A

OWNERSHIP DOCUMENT

Company: Hoth Therapeutics, Inc.
Filed: February 16, 2021
Period of Report: May 26, 2020
Accession Number: 0001213900-21-009744

View Document ↗ View on SEC.gov ↗